東北大学

東北大学大学院医学系研究科
腎臓内科学分野
東北大学病院　腎臓・高血圧内科

論文・著書

～歴史ある論文・著書～

2017年

論文【英文】

  1. Omura K, Ota H, Takahashi Y, Matsuura T, Seiji K, Arai Y, Morimoto R, Satoh F, Takase K: Anatomical Variations of the Right Adrenal Vein: Concordance Between Multidetector Computed Tomography and Catheter Venography. Hypertension 69(3); 428-434, 2017
  2. Mori T, Osaki Y, Oba-Yabana I, Ito S: Diuretic Usage for Protection against End-Organ Damage in Liver Cirrhosis and Heart Failure. Hepatol Res.　47(1); 11-22, 2017
  3. Hayashi S, Oe Y, Fushima T, Sato E, Sato H, Ito S, Takahashi N: Protease-activated receptor 2 exacerbates adenine-induced renal tubulointerstitial injury in mice. Biochem Biophys Res Commun. 483(1):547-552, 2017
  4. Fushima T, Sekimoto A, Oe Y, Sato E, Ito S, Sato H, Takahashi N: Nicotinamide ameliorates a preeclampsia-like condition in mice with reduced uterine perfusion pressure. Am J Physiol Renal Physiol. 312(2):F366-F372, 2017
  5. Nezu M, Souma T, Yu L, Suzuki T, Saigusa D, Ito S, Suzuki N, Yamamoto M: Transcription factor Nrf2 hyperactivation in early-phase renal ischemia-reperfusion injury prevents tubular damage progression. Kidney Int 91(2):387-401, 2017
  6. Saito A, Kimura T, Takeuchi Y, Matsuda K, Fukami H, Sato H, Iwakura Y, Sato H, Nagasawa T: A case of rapid progression of Fabry nephropathy with remarkable glomerulomegaly: a case report and mini literature review of weak response to enzyme replacement therapy (ERT). Renal Replacement Therapy 2017(Open Access)
  7. Suzuki T, Seki S, Hiramoto K, Naganuma E, Kobayashi EH, Yamaoka A, Baird L, Takahashi N, Sato H, Yamamoto M: Nat Commun 8:14577, 2017
  8. Yamazaki Y, Nakamura Y, Omata K, Ise K, Tezuka Y, Ono Y, Morimoto R,Nozawa Y, Gomez-Sanchez CE, Tomlins SA, Rainey WE, Ito S, Satoh F, Sasano H:Histopathological classification of cross-sectional image negativehyperaldosteronism. J Clin Endocrinol Metab.102; 1182-1192, 2017
  9. Ogawa S, Takiguchi J, Shimizu M, Nako K, Okamura M, Kinouchi Y, Ito S: The relationship between the renal reabsorption of cysteine and the lowered urinary pH in diabetics. Clin Exp Nephrol. 21; 1044-1052, 2017
  10. Chang CH, Hu YH, Tsai YC, Wu CH, Wang SM, Lin LY, Lin YH, Satoh F,Wu KD, Wu VC: Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy.Oncotarget 8(18):29984-29995, 2017
  11. Shima H, Sasaki K, Suzuki T, Mukawa C, Obara T, Oba Y, Matsuo A, Kobayashi T, Mishima E, Watanabe S, Akiyama Y, Kikuchi K, Matsuhashi T, Oikawa Y, Nanto F, Akiyama Y, Ho HJ, Suzuki C, Saigusa D, Masamune A, Tomioka Y, Masaki T, Ito S, Hayashi KI, Abe T: A novel indole compound MA-35 attenuates renal fibrosis by inhibiting both TNF-α and TGF-β1 pathways. Sci Rep.7(1):1884, 2017
  12. Schiffrin EL, Calhoun DA, Flack JM, Ito S, Webb RC: Update From the Editors to Our Readers. Am J Hypertens 30(1):1-2, 2017
  13. Satoh F, Sasano H, Yamazaki Y, Ito S: Aldosterone-Producing Adenomas: Genotypes and Phenotypes. Hypertension 70(1):38-41, 2017
  14. Morimoto R, Ono Y, Tezuka Y, Kudo M, Yamamoto S, Arai T, Gomez-Sanchez CE, Sasano H, Ito S, Satoh F: Rapid Screening of Primary Aldosteronism by a Novel Chemiluminescent Immunoassay. Hypertension. 70(2); 334-341, 2017
  15. Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5(9):689-699, 2017
  16. Fujimura T, Kambayashi Y, Furudate S, Kakizaki A, Hidaka T, Haga T, Hashimoto A, Morimoto R, Aiba S:Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.J Dermatol. 44(3); e13-14, 2017
  17. Mishima E, Fukuda S, Mukawa C, Yuri A, Kanemitsu Y, Matsumoto Y, Akiyama Y, Fukuda NN, Tsukamoto H, Asaji K, Shima H, Kikuchi K, Suzuki C, Suzuki T, Tomioka Y, Soga T, Ito S, Abe T. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Kidney Int. 92(3):634-645, 2017
  18. Shimada H, Kogure N, Noro E, Kudo M, Sugawara K, Sato I, Shimizu K, Kobayashi M, Suzuki D, Parvin R, Saito-Ito T, Uruno A, Saito-Hakoda A, Rainey WE, Ito S, Yokoyama A, Sugawara A: High glucose stimulates expression of aldosterone synthase (CYP11B2) and secretion of aldosterone in human adrenal cells. FEBS Open Bio 7(9):1410-1421, 2017
  19. Nakayama M, Itami N, Suzuki H, Hamada H, Osaka N, Yamamoto R, Tsunoda K, Nakano H, Watanabe K, Zhu WJ, Maruyama Y, Terawaki H, Kabayama S, Nakazawa R, Miyazaki M, Ito S: Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation. PLoS One 12(9):e0184535, 2017
  20. Suzuki D, Saito-Hakoda A, Ito R, Shimizu K, Parvin R, Shimada H, Noro E, Suzuki S, Fujiwara I, Kagechika H, Rainey WE, Kure S, Ito S, Yokoyama A, Sugawara A: Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure. PLoS One 12(8):e0181055, 2017
  21. Mishima E, Maruyama K, Nakazawa T, Abe T, Ito S: Acute Kidney Injury from Excessive Potentiation of Calcium-channel Blocker via Synergistic CYP3A4 Inhibition by Clarithromycin Plus Voriconazole. Intern Med 56(13):1687-1690, 2017
  22. Hashimoto J, Ito S: Central diastolic pressure decay mediates the relationship between aortic stiffness and myocardial viability: potential implications for aortosclerosis-induced myocardial ischemia. J Hypertens 35(10):2034-2043, 2017
  23. Mishima E, Suzuki T, Seiji K, Akiyama Y, Ota H, Hashimoto J, Takase K, Abe T, Ito S: Selective embolization therapy for intrarenal artery stenosis causing renovascular hypertension: Efficacy and follow-up renal imaging. J Clin Hypertens (Greenwich). 19(10):1028-1031, 2017
  24. Mishima E, Suzuki T, Hashimoto J, Abe T, Ito S: 'Lead pipe'-like stiff aorta with grossly widened pulse pressure in burned-out Takayasu arteritis. Eur Heart J Cardiovasc Imaging. 18(7):819, 2017
  25. Matsuhashi T, Sato T, Kanno SI, Suzuki T, Matsuo A, Oba Y, Kikusato M, Ogasawara E, Kudo T, Suzuki K, Ohara O, Shimbo H, Nanto F, Yamaguchi H, Saigusa D, Mukaiyama Y, Watabe A, Kikuchi K, Shima H, Mishima E, Akiyama Y, Oikawa Y, Hsin-Jung HO, Akiyama Y, Suzuki C, Uematsu M, Ogata M, Kumagai N, Toyomizu M, Hozawa A, Mano N, Owada Y, Aiba S, Yanagisawa T, Tomioka Y, Kure S, Ito S, Nakada K, Hayashi KI, Osaka H, Abe T: Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases. EBioMedicine. 20:27-38, 2017
  26. Mishima E, Mori T, Sohara E, Uchida S, Abe T, Ito S: Inherited, not acquired, Gitelman syndrome in a patient with Sjögren's syndrome: importance of genetic testing to distinguish the two forms. CEN Case Rep. 6(2); 180-184, 2017
  27. Yamamoto T, Miyazaki M, Nakayama M, Yamada G, Matsushima M, Sato M, Sato T, Taguma Y, Sato H, Ito S: Erratum to: Impact of hemoglobin levels on renal and non-renal clinical outcomes differs by chronic kidney disease stages: the Gonryo study. Clin Exp Nephrol. 21; 1140, 2017
  28. Fujikura E, Akiu M, Miyauchi K, Yoshida M, Aoki S, Yamamoto T, Narumi K, Yanagisawa N, Nakamichi T, Miyazaki M, Sato H, Ito S: Blood Purification therapies in methotrexate-induced acute kidney injury: four case reports; Renal Replacement Therapy 3; 48, 2017
  29. Nezu M, Suzuki N, Yamamoto M: Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression. Am J Nepfrol 45(6): 473-483,2017 doi: 10.1159/000475890. PMID: 28502971
  30. Nezu M, Souma T, Yu L, Sekine H, Takahashi N, Wei AZ, Ito S, Fukamizu A, Zsengeller ZK, Nakamura T, Hozawa A, Karumanchi SA, Suzuki N, Yamamoto M: Nrf2 inactivation enhances placental angiogenesis in a preeclampsia mouse model and improves maternal and fetal outcomes. Sci Signal 2017; 10(479): eaam5711. doi: 10.1126/scisignal.aam5711. PMID: 28512147
  31. Yu L, Takai J, Otsuki A, Katsuoka F, Suzuki M, Katayama S, Nezu M, Engel JD, Moriguchi T, Yamamoto M: Derepression of the DNA Methylation Machinery of the Gata1 Gene Triggers the Differentiation Cue for Erythropoiesis. Mol Cell Biol 37(8): e00592-16, 2017 doi: 10.1128/MCB.00592-16. PMID: 28069743
  32. Yu L, Moriguchi T, Kaneko H, Hayashi M, Hasegawa A, Nezu M, Saya H, Yamamoto M, Shimizu R: Reducing Inflammatory Cytokine Production from Renal Collecting Duct Cells by Inhibiting GATA2 Ameliorates Acute Kidney Injury. Mol Cell Biol. 37(22). pii: e00211-17, 2017 doi: 10.1128/MCB.00211-17. PMID: 28807932
  33. Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S: Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques. Toxins (Basel). 10(1), pii: E19, 2017
  34. Omata K, Anand SK, Hovelson DH, Liu CJ, Yamazaki Y, Nakamura Y, Ito S, Satoh F, Sasano H, Rainey WE, Tomlins SA: Aldosterone-Producing Cell Clusters Frequently Harbor Somatic Mutations and Accumulate With Age in Normal Adrenals. J Endocr Soc. 1(7):787-799, 2017
  35. Nakayama M, Zhu WJ, Watanabe K, Gibo A, Sherif AM, Kabayama S, Ito S: Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity. BMC Nephrol. 18(1):327, 2017

論文【邦文】

  1. 寺脇博之、中山恵輔、中山昌明、伊藤貞嘉：メチルグリオキサールと心腎連関；循環器内科82(4)；365-369, 2017
  2. 小川晋：腎アミノ酸代謝と腎糖新生；循環器内科82(4); 313-320, 2017
  3. 鈴木健弘、阿部高明：ミトコンドリア病の治療と心疾患；循環器内科82(4); 375-384, 2017

著書【分担執筆】

  1. 伊藤貞嘉：利尿薬；治療薬UP-TO-DATE 2017；メディカルレビュー社；251-253, 2017.1.20
  2. 伊藤貞嘉：腎実質性高血圧；1336専門家による私の治療2017-2018年度版；日本医事新報社；532-533, 2017.7.28
TOP